|
🐜
|
Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy
22 auth.
Leo Nicolai,
Alexander Leunig,
Sophia Brambs,
R. Kaiser,
Tobias Weinberger,
Michael Weigand,
M. Muenchhoff,
J. Hellmuth,
S. Ledderose,
Heiko Schulz,
...
C. Scherer,
M. Rudelius,
M. Zoller,
Dominik J. Hoechter,
O. Keppler,
D. Teupser,
B. Zwissler,
M. von Bergwelt-Baildon,
S. Kääb,
S. Massberg,
Kami Pekayvaz,
K. Stark
|
8 |
2020 |
8
🐜
|
|
🐜
|
Reversal of tumor acidosis by systemic buffering reactivates NK cells to express IFN‐γ and induces NK cell‐dependent lymphoma control without other immunotherapies
9 auth.
Johann Pötzl,
David J Roser,
L. Bankel,
Nadine Hömberg,
Albert Geishauser,
Christoph D. Brenner,
...
Michael Weigand,
M. Röcken,
R. Mocikat
|
6 |
2017 |
6
🐜
|
|
🐜
|
High‐resolution serum proteome trajectories in COVID‐19 reveal patient‐specific seroconversion
14 auth.
Philipp E. Geyer,
Florian M. Arend,
S. Doll,
Marie-Luise Louiset,
Sebastian Virreira Winter,
Johannes B. Müller-Reif,
Furkan M. Torun,
Michael Weigand,
P. Eichhorn,
M. Bruegel,
...
Maximilian T. Strauss,
L. Holdt,
Matthias Mann,
D. Teupser
|
6 |
2021 |
6
🐜
|
|
🐜
|
Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis
8 auth.
C. Blaser,
M. Klein,
D. Grandgirard,
M. Wittwer,
H. Peltola,
Michael Weigand,
...
U. Koedel,
S. Leib
|
4 |
2010 |
4
🐜
|
|
🐜
|
Does the cytokine adsorber CytoSorb® reduce vancomycin exposure in critically ill patients with sepsis or septic shock? a prospective observational study
10 auth.
C. Scharf,
F. Weinelt,
I. Schroeder,
M. Paal,
Michael Weigand,
M. Zoller,
...
M. Irlbeck,
C. Kloft,
J. Briegel,
U. Liebchen
|
4 |
2022 |
4
🐜
|
|
🐜
|
High-resolution longitudinal serum proteome trajectories in COVID-19 reveal patients-specific seroconversion
14 auth.
Philipp E. Geyer,
Florian M. Arend,
Sophia Doll,
Marie-Luise Louiset,
S. V. Winter,
Johannes B. Müller-Reif,
Furkan M. Torun,
Michael Weigand,
P. Eichhorn,
M. Bruegel,
...
Maximilian T. Strauss,
L. Holdt,
Matthias Mann,
D. Teupser
|
3 |
2021 |
3
🐜
|
|
🐜
|
SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS
9 auth.
Marie-Luise Buchholtz,
Florian M. Arend,
P. Eichhorn,
Michael Weigand,
A. Kleinhempel,
Kurt Häusler,
...
M. Bruegel,
L. Holdt,
D. Teupser
|
1 |
2021 |
1
🐜
|
|
🐬
|
Overview of NCBI's SARS-CoV-2 submission process and the metadata required v2
Ruth E E Timme,
E. Griffiths,
L. Katz,
Michael Weigand,
Technical Outreach and Assistance for States Team
|
0 |
2022 |
0
🐬
|
|
🐜
|
SP270Hyperkalemia is less frequent when point-of-care methods are used
7 auth.
Marie-Luise Buchholtz,
U. Schoenermarck,
M. Paal,
Michael Weigand,
Martin Winkels,
Frederick M Kleine,
...
M. Fischereder
|
0 |
2019 |
0
🐜
|
